Skip to main content

Advertisement

SpringerLink
Log in

Cryptococcus gattii Comparative Genomics and Transcriptomics: A NIH/NIAID White Paper

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Cryptococcus gattii is an emerging global pathogen. Recent reports suggest that C. gattii cryptococcosis is more common in immunocompetent as well as HIV-infected AIDS patients than earlier estimated. An ongoing outbreak of C. gattii in Vancouver, Canada, and the US Pacific Northwest has heightened public health awareness in North America. We have few clues as to what causes emergence or re-emergence of highly pathogenic strains, why C. gattii split up from its sibling pathogen C. neoformans, why it thrives in trees instead, and why immunocompetent individuals are vulnerable to this pathogen? C. gattii comprises of four distinct lineages, but the information on the genome of C. gattii is inadequate and unrepresentative as it is limited to two strains, R265 and WM276, which are MATα, serotype B, genotype VGII/VGI from Canada and Australia, respectively. There is a wide gap in knowledge about the genomes of VGIII and VGIV strains, serotype C strains, and MATa strains. The geographical representation is inadequate in the absence of strains from California, South America, Asia, and Africa. Additional obstacles to work with this pathogen are the following: (a) complex molecular typing schemes and (b) lack of functional genomics analyses. We propose to complete genome sequencing of 12 reference strains by next-generation sequencing technology and to map their transcriptomes by RNA-Seq technology. This effort would lead to new resources for the scientific community including (1) insight from additional C. gattii genomes to anchor future research studies, (2) validation of single-nucleotide polymorphisms (SNPs) for molecular typing to improve epidemiology studies, and (3) transcript analyses from strains under relevant pathogenic and non-pathogenic conditions to accelerate the discovery of proteins for diagnostics, drug targets, and vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vanbreuseghem R, Takashio M. An atypical strain of Cryptococcus neoformans (San Felice) Vuillemin 1894. II. Cryptococcus neoformans var. gattii var. nov. Ann Soc Belg Med Trop. 1970;50(6):695–702.

  2. Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A, editors. Cryptococcus: from human pathogen to model yeast. Washington: ASM Press; 2010.

    Google Scholar 

  3. Chaturvedi V, Chaturvedi S. Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol. 2011;19(11):564–71.

    Article  PubMed  CAS  Google Scholar 

  4. Springer DJ, Chaturvedi V. Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis. 2010;16:14–20.

    Article  PubMed  Google Scholar 

  5. Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, Kwon-Chung KJ. Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis. 2008;14(5):755–62.

    Article  PubMed  CAS  Google Scholar 

  6. Litvintseva AP, Thakur R, Reller LB, Mitchell TG. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis. 2005;192(5):888–92.

    Google Scholar 

  7. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V. Cryptococcus gattii in AIDS patients, Southern California. Emerg Infect Dis. 2005;11:1686–92.

    Article  PubMed  CAS  Google Scholar 

  8. Dora JM, Kelbert S, Deutschendorf C, Cunha VS, Aquino VR, Santos RP, et al. Cutaneous cryptococccosis due to Cryptococcus gattii in immunocompetent hosts: case report and review. Mycopathologia. 2006;161(4):235–8.

    Article  PubMed  Google Scholar 

  9. Galanis E, Hoang L, Kibsey P, Morshed M, Phillips P. Clinical presentation, diagnosis and management of Cryptococcus gattii cases: lessons learned from British Columbia. Can J Infect Dis Med Microbiol. 2009;20(1):23–8.

    Google Scholar 

  10. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian cryptococcal study group. Clin Infect Dis. 2000;31(2):499–508.

    Google Scholar 

  11. Harris JR, Lockhart SR, Debess E, Marsden-Haug N, Goldoft M, Wohrle R, et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis. 2011. doi:10.1093/cid/cir723

  12. Stephen C, Lester S, Black W, Fyfe M, Raverty S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J. 2002;43(10):792–4.

    PubMed  Google Scholar 

  13. Bovers M, Hagen F, Kuramae EE, Boekhout T. Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing. Fungal Genet Biol. 2008;45(4):400–21.

    Article  PubMed  CAS  Google Scholar 

  14. D’Souza CA, Kronstad JW, Taylor G, Warren R, Yuen M, Hu G, et al. Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio. 2011;2(1):e00342–10.

  15. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA. 2004;101(49):17258–63.

    Google Scholar 

  16. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984;120(1):123–30.

    Google Scholar 

  17. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135–45.

    Article  PubMed  CAS  Google Scholar 

  18. Metzker ML. Sequencing technologies—the next generation. Nature reviews. 2008;11(1):31–46.

    Google Scholar 

  19. DiGuistini S, Liao N, Platt D, Robertson G, Seidel M, Chan S, et al. De novo genome sequence assembly of a filamentous fungus using Sanger, 454 and Illumina sequence data. Genome Biol. 2009;10(9):1–12.

    Article  Google Scholar 

  20. Martin F, Cullen D, Hibbett D, Pisabarro A, Spatafora JW, Baker SE, et al. Sequencing the fungal tree of life. New Phytol. 2011;190(4):818–21.

    Article  PubMed  CAS  Google Scholar 

  21. Buée M, Reich M, Murat C, Morin E, Nilsson RH, Uroz S, et al. 454 Pyrosequencing analyses of forest soils reveal an unexpectedly high fungal diversity. New Phytol. 2009;184(2):449–56.

    Article  PubMed  Google Scholar 

  22. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev. 2009;10(1):57–63.

    Article  CAS  Google Scholar 

  23. Morozova O, Hirst M, Marra MA. Applications of new sequencing technologies for transcriptome analysis. Annu Rev Genomics Hum Genet. 2009;10:135–51.

    Article  PubMed  CAS  Google Scholar 

  24. Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev. 2010;12(2):87–98.

    Google Scholar 

  25. Bruno VM, Wang Z, Marjani SL, Euskirchen GM, Martin J, Sherlock G, et al. Comprehensive annotation of the transcriptome of the human fungal pathogen Candida albicans using RNA-seq. Genome Res. 2010;20(10):1451–8.

    Google Scholar 

  26. Gibbons JG, Beauvais A, Beau R, McGary KL, Latge J-P, Rokas A. Global transcriptome changes underlying colony growth in the opportunistic human pathogen Aspergillus fumigatus. Eukaryotic Cell. 2011:EC.05102-11. doi:10.1128/EC.05102-11

  27. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol. 2009;47(6):561–70.

    Article  PubMed  CAS  Google Scholar 

  28. Krockenberger M, Malik R, Ngamskulrungroj P, Trilles L, Escandon P, Dowd S, et al. Pathogenesis of pulmonary Cryptococcus gattii infection: a rat model. Mycopathologia. 2010;170(5):315–30.

    Article  PubMed  Google Scholar 

  29. Ngamskulrungroj P, Gilgado F, Faganello J, Litvintseva AP, Leal AL, Tsui KM, et al. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One. 2009;4(6):e5862.

    Article  PubMed  Google Scholar 

  30. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature. 2005;437:1360–4.

  31. Byrnes EJ, III, Li W, Lewit Y, Ma H, Voelz K, Ren P, et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog. 2010;6(4):e1000850.

  32. Kluger EK, Karaoglu HK, Krockenberger MB, Della Torre PK, Meyer W, Malik R. Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13-year period in a Birman cat. Med Mycol. 2006;44(6):561–6.

    Article  PubMed  CAS  Google Scholar 

  33. Kwon-Chung KJ. A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia. 1976;68(4):943–6.

    Google Scholar 

  34. Chaturvedi S, Ren P, Narasipura SD, Chaturvedi V. Selection of optimal host strain for molecular pathogenesis studies on Cryptococcus gattii. Mycopathologia. 2005;160(3):207–15.

    Article  PubMed  Google Scholar 

  35. Loperena-Alvarez Y, Ren P, Li X, Schoonmaker-Bopp DJ, Ruiz A, Chaturvedi V, et al. Genotypic characterization of environmental isolates of Cryptococcus gattii from Puerto Rico. Mycopathologia. 2010;170(4):279–85.

    Article  PubMed  Google Scholar 

  36. Varma A, Kwon-Chung KJ. Heteroresistance of Cryptococcus gattii to Fluconazole. Antimicrob Agents Chemother. 2010;54(6):2303–11.

  37. Ngamskulrungroj P, Price J, Sorrell T, Perfect JR, Meyer W, Wang P. Cryptococcus gattii virulence composite: candidate genes revealed by microarray analysis of high and less virulent Vancouver Island outbreak strains. PLoS One. 2010;6(1):155–68.

    Google Scholar 

Download references

Acknowledgments

We thank the participants for their input in the White Paper. VC thanks authorities at the New York State Department of Health for an offsite assignment, which made this task possible.

Author information

Authors and Affiliations

  1. Mycology Laboratory, New York State Department of Health, Wadsworth Center, Albany, NY, USA

    V. Chaturvedi

  2. Department of Biomedical Sciences, University at Albany, Albany, NY, USA

    V. Chaturvedi

  3. Infectious Diseases Program, J. Craig Venter Institute, Rockville, MD, USA

    W. C. Nierman

Authors
  1. V. Chaturvedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. C. Nierman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Chaturvedi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaturvedi, V., Nierman, W.C. Cryptococcus gattii Comparative Genomics and Transcriptomics: A NIH/NIAID White Paper. Mycopathologia 173, 367–373 (2012). https://doi.org/10.1007/s11046-011-9512-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-011-9512-9

Keywords

Search

Navigation